Hideharu Abe
Impact in
- Nephrology top 1%
- Chronic Kidney Disease and Diabetes
- Renal Diseases and Glomerulopathies
- Parathyroid Disorders and Treatments
- Clinical Biochemistry top 5%
- Advanced Glycation End Products research
Papers in
- Nephrology 35
- Chronic Kidney Disease and Diabetes 24
- Renal Diseases and Glomerulopathies 19
-
- TGF-β signaling in diseases 12
- Connective Tissue Growth Factor Research 8
- Amyloidosis: Diagnosis, Treatment, Outcomes 6
- Co-authors
- Toshio Doi (50 shared papers)Kojiro Nagai (48 shared papers)Toru Kita (15 shared papers)Takeshi Matsubara (17 shared papers)Hidenori Arai (13 shared papers)Noriyuki Iehara (16 shared papers)Toshikazu Takahashi (11 shared papers)Atsushi Fukatsu (11 shared papers)
- Journals
- Journal of Biological Chemistry (7 papers)PLoS ONE (6 papers)The Journal of Medical Investigation (5 papers)Biochemical and Biophysical Research Communications (4 papers)Scientific Reports (4 papers)
- Partner nations
- JapanUnited StatesUnited Kingdom
In The Last Decade
Hideharu Abe
65 papers receiving 1.3k citations
Peers
Comparison fields: 5 of 93
- Nephrology 503
- Clinical Biochemistry 126
- Pathology and Forensic Medicine 143
- Endocrinology, Diabetes and Metabolism 121
- Molecular Biology 468
Countries citing papers authored by Hideharu Abe
This map shows the geographic impact of Hideharu Abe's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Hideharu Abe with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Hideharu Abe more than expected).
Fields of papers citing papers by Hideharu Abe
This network shows the impact of papers produced by Hideharu Abe. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Hideharu Abe. The network helps show where Hideharu Abe may publish in the future.
Co-authors
The 25 scholars most cited alongside Hideharu Abe, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 67 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | 2007 | 146 | |
| 2 | 2001 | 120 | |
| 3 | 2004 | 80 | |
| 4 | 2006 | 72 | |
| 5 | 2006 | 66 | |
| 6 | 2008 | 60 | |
| 7 | 2018 | 58 | |
| 8 | 2017 | 52 | |
| 9 | 2005 | 50 | |
| 10 | 2004 | 49 | |
| 11 | 2011 | 46 | |
| 12 | 2019 | 38 | |
| 13 | 2015 | 37 | |
| 14 | 1999 | 32 | |
| 15 | 2011 | 31 | |
| 16 | 2011 | 30 | |
| 17 | 2009 | 29 | |
| 18 | 2011 | 28 | |
| 19 | 2012 | 25 | |
| 20 | 2010 | 24 |
About Hideharu Abe
Hideharu Abe is a scholar working on Nephrology, Molecular Biology, Surgery, Pulmonary and Respiratory Medicine and Oncology, having authored 67 papers that have together received 1.4k indexed citations. Recurring topics across this work include Chronic Kidney Disease and Diabetes (24 papers), Renal Diseases and Glomerulopathies (19 papers), TGF-β signaling in diseases (12 papers), Connective Tissue Growth Factor Research (8 papers), Amyloidosis: Diagnosis, Treatment, Outcomes (6 papers), Renal and Vascular Pathologies (4 papers), Advanced Glycation End Products research (4 papers) and Cell Adhesion Molecules Research (4 papers). The work is most often cited by research in Nephrology (503 citations), Clinical Biochemistry (126 citations), Pathology and Forensic Medicine (143 citations), Endocrinology, Diabetes and Metabolism (121 citations) and Molecular Biology (468 citations). Hideharu Abe has collaborated with scholars based in Japan, United States and United Kingdom. Frequent co-authors include Toshio Doi, Kojiro Nagai, Toru Kita, Takeshi Matsubara, Hidenori Arai, Noriyuki Iehara, Toshikazu Takahashi, Atsushi Fukatsu, Seiji Kishi and Tatsuya Tominaga. Their work appears in journals such as Journal of Biological Chemistry, PLoS ONE, The Journal of Medical Investigation, Biochemical and Biophysical Research Communications and Scientific Reports.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.